Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions
Fiona M. Laird, Huaibin Cai, Alena Savonenko, et al.
Journal of Neuroscience (2005) Vol. 25, Iss. 50, pp. 11693-11709
Open Access | Times Cited: 514

Showing 51-75 of 514 citing articles:

Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story
Ugo Ala
Cells (2020) Vol. 9, Iss. 7, pp. 1574-1574
Open Access | Times Cited: 146
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
Eric McDade, Iryna Voytyuk, Paul Aisen, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 703-714
Closed Access | Times Cited: 105
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
Ali Azargoonjahromi
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 4
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Masuo Ohno, Sarah L. Cole, Marina V. Yasvoina, et al.
Neurobiology of Disease (2006) Vol. 26, Iss. 1, pp. 134-145
Open Access | Times Cited: 282
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Ludovico Minati, Trudi Edginton, Maria Grazia Bruzzone, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2008) Vol. 24, Iss. 2, pp. 95-121
Open Access | Times Cited: 262
The Role of Amyloid Precursor Protein Processing by BACE1, the β-Secretase, in Alzheimer Disease Pathophysiology
Sarah L. Cole, Robert Vassar
Journal of Biological Chemistry (2008) Vol. 283, Iss. 44, pp. 29621-29625
Open Access | Times Cited: 242
Amyloid-β as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar, Gregory J. Brewer
Journal of Alzheimer s Disease (2010) Vol. 22, Iss. 3, pp. 741-763
Open Access | Times Cited: 231
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
Jasjeet Kaur Sahni, Sihem Doggui, Javed Ali, et al.
Journal of Controlled Release (2010) Vol. 152, Iss. 2, pp. 208-231
Closed Access | Times Cited: 205
Early Oligodendrocyte/Myelin Pathology in Alzheimer's Disease Mice Constitutes a Novel Therapeutic Target
Maya Desai, Michael A. Mastrangelo, Deborah A. Ryan, et al.
American Journal Of Pathology (2010) Vol. 177, Iss. 3, pp. 1422-1435
Open Access | Times Cited: 205
Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells
Elina Sutinen, Tuula Pirttilä, George Anderson, et al.
Journal of Neuroinflammation (2012) Vol. 9, Iss. 1
Open Access | Times Cited: 199
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
Ying Liu, Mi‐Jeong Yoo, Alena Savonenko, et al.
Journal of Neuroscience (2008) Vol. 28, Iss. 51, pp. 13805-13814
Open Access | Times Cited: 197
Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
Yasuyuki Mitani, Junko Yarimizu, Kyoko Saita, et al.
Journal of Neuroscience (2012) Vol. 32, Iss. 6, pp. 2037-2050
Open Access | Times Cited: 186
Neurotrophins, synaptic plasticity and dementia
Ottavio Arancio, Moses V. Chao
Current Opinion in Neurobiology (2007) Vol. 17, Iss. 3, pp. 325-330
Closed Access | Times Cited: 185
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Virginie Buggia-Prévot, Celia Fernandez, Sean M. Riordan, et al.
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 185
Mitochondrial Dysfunction in Aging and Alzheimer's Disease: Strategies to Protect Neurons
P. Hemachandra Reddy
Antioxidants and Redox Signaling (2007) Vol. 9, Iss. 10, pp. 1647-1658
Closed Access | Times Cited: 182
BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate
Nobumasa Takasugi, Tomoki Sasaki, K. Suzuki, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 18, pp. 6850-6857
Open Access | Times Cited: 176
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
Yang Liu, Sai An, Jianfeng Li, et al.
Biomaterials (2015) Vol. 80, pp. 33-45
Closed Access | Times Cited: 166
The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo
Lujia Zhou, Soraia Barão, Mathias Laga, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 31, pp. 25927-25940
Open Access | Times Cited: 161
BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease
Soraia Barão, Diederik Moechars, Stefan F. Lichtenthaler, et al.
Trends in Neurosciences (2016) Vol. 39, Iss. 3, pp. 158-169
Closed Access | Times Cited: 161
Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Harald Hampel, Yong Shen, Dominic M. Walsh, et al.
Experimental Neurology (2009) Vol. 223, Iss. 2, pp. 334-346
Open Access | Times Cited: 157
Amyloid beta mediates memory formation
Ana García‐Osta, Cristina M. Alberini
Learning & Memory (2009) Vol. 16, Iss. 4, pp. 267-272
Open Access | Times Cited: 157
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Xiangyou Hu, Xiangdong Zhou, Weifeng He, et al.
Journal of Neuroscience (2010) Vol. 30, Iss. 26, pp. 8819-8829
Open Access | Times Cited: 151
Secretase inhibitors and modulators for Alzheimer’s disease treatment
Taisuke Tomita
Expert Review of Neurotherapeutics (2009) Vol. 9, Iss. 5, pp. 661-679
Closed Access | Times Cited: 148
β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
Brian D. Hitt, Sean M. Riordan, Lokesh Kukreja, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 46, pp. 38408-38425
Open Access | Times Cited: 138

Scroll to top